SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950153-97-000469
Filing Date
1997-05-09
Accepted
1997-05-09 00:00:00
Documents
13
Period of Report
1997-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 1997. 10-Q 46802
2 AMENDMENT #2 TO RIGHTS AGREEMENT EX-4.1.B 41553
3 ASSET PURCHASE AGRMNT BTWN COMPANY AND SYNTEX INT. EX-10.79 82228
4 ASSET PURCHASE AGRMNT BTWN COMPANY AND SYNTEX USA EX-10.80 104832
5 ASSET PURCHASE AGRMNT BTWN COMPANY AND HOFFMAN EX-10.81 91446
6 ASSET PURCHASE AGRMNT BTWN COMPANY AND SYNTEX PIL EX-10.82 83155
7 TRANSITION SERVICES AGRMNT BTWN COMPANY & HOFFMAN EX-10.83 25848
8 TRANSITION SERVICES AGRMNT BTWN COMPANY & HOFFMAN EX-10.84 24841
9 SUPPLY AGRMNT BTWN COMPANY AND SYNTEX PIL EX-10.85 41008
10 LICENSE AGRMNT COMPANY AND PLATIUM SOFTWARE CORP. EX-10.86 49310
11 MASTER SOFTWARE LICENSE BTWN COMPANY & FOCUSSOFT EX-10.87 17567
12 STATEMENTS RE: COMPUTATIONS OF PER SHARE EARNINGS EX-11.1 2318
13 FINANCIAL DATA SCHEDULE EX-27 2370
  Complete submission text file 0000950153-97-000469.txt   616240
Mailing Address 4343 E CAMELBACK RD SUITE 250 PHOENIX AZ 85018
Business Address 4343 EAST CAMELBACK RD PHOENIX AZ 85018 2125992000
MEDICIS PHARMACEUTICAL CORP (Filer) CIK: 0000859368 (see all company filings)

IRS No.: 521574808 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-18443 | Film No.: 97598560
SIC: 2834 Pharmaceutical Preparations